Press release

Cardiovascular MRI scanner from Siemens Healthineers redefines treatment pathways in cardiovascular medicine

ESC Congress 2018, August 25 to 29, 2018, Munich, Stand H400

Published on August 25, 2018


Data on file


Source: von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. Journal of cardiovascular magnetic resonance: Official Journal of the Society for Cardiovascular Magnetic Resonance. 2016;18:6. doi: 10.1186/s12968-016-0225-6. PubMed PMID: 26800662; PubMed Central PMCID: PMC4724113.


Magnetom Sola bears the CE mark and is available in the European Union and in other countries. Product availability may vary from country to country and is subject to the relevant statutory requirements. Please contact your nearest branch if you have any queries relating to availability.

Information for US readers: Magnetom Sola is 510(k) pending and is therefore not yet commercially available. Future availability cannot be guaranteed. Please contact your local Siemens organization for more detailed information on this subject.

Siemens Healthineers

Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2017, which ended on September 30, 2017, Siemens Healthineers generated revenue of €13.8 billion and profit of €2.5 billion and has about 48,000 employees worldwide.